Effects of topical formoterol alone and in combination with budesonide in a pollen season model of allergic rhinitis

Respiratory Medicine

Volumn 101, Issue 6, 2007, Pages 1106-1112

  Ahlström Emanuelsson, Cecilia ^a   Andersson, Morgan ^a   Persson, Carl G A ^a   Thorsson, Lars ^b   Greiff, Lennart ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Airway; ECP; Inflammation; Plasma exudation; Tryptase

Indexed keywords

ALPHA 2 MACROGLOBULIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; EOSINOPHIL CATIONIC PROTEIN; FORMOTEROL; GLUCOCORTICOID; HISTAMINE; PLACEBO; POLLEN ANTIGEN; TRYPTASE;

ADULT; ALLERGIC RHINITIS; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; EOSINOPHIL; FEMALE; HUMAN; MALE; MAST CELL; MONOTHERAPY; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SYMPTOM;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; ALLERGENS; BRONCHODILATOR AGENTS; BUDESONIDE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; HUMANS; MALE; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX;

EID: 34247622510     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.11.017     Document Type: Article

References (24)

1. Persson C.G.A., Erjefält I., and Andersson P. Leakage of macromolecules from guinea-pig tracheobronchial microcirculation: effects of allergen, leukotrienes, tachykinins and anti-asthma drugs. Acta Physiol Scand 127 (1986) 95-105
2. Erjefält I., and Persson C.G.A. Long duration and high potency of anti-exudative effects of formoterol in guinea-pig tracheobronchial airways. Am Rev Respir Dis 144 (1991) 788-791
3. Tokuyama K., Lötvall J.O., Löfdahl C.-G., Barnes P.J., and Chung K.F. Inhaled formoterol inhibits histamine-induced airflow obstruction and airway microvascular leakage. Eur J Pharmacol 193 (1991) 35-39
4. Advenier C., Qian Y., Koune J.D., Molimard M., Candenas M.L., and Naline E. Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea-pig. Br J Pharmacol 105 (1992) 792-798
5. 2-agonists on histamine-induced airway microvascular leakage in ozone-exposed guinea pigs. Am J Respir Crit Care Med 156 (1997) 723-727
6. O'Donnell S.R., and Anderson G.P. The effects of formoterol on plasma exudation produced by a localized acute inflammatory response to bradykinin in the tracheal mucosa of rats in vivo. Br J Pharmacol 116 (1995) 1571-1576
7. 2-adrenergic receptor agonist formoterol reduces microvascular leakage by inhibiting endothelial gap formation. Am J Physiol 266 (1994) L461-L468
8. Svensson C., Greiff L., Andersson M., Alkner U., Grönneberg R., and Persson C.G.A. Antiallergic actions of high topical doses of terbutaline in human nasal airways. Allergy 50 (1995) 884-890
9. Proud D., Reynolds C.J., Lichtenstein M., and Kagey-Sobotka A. Intranasal salmeterol inhibits allergen-induced vascular permeability but not mast cell activation or cellular infiltration. Clin Exp Allergy 28 (1998) 868-875
10. Assem E.S.K., and Schildt H.O. Inhibition by sympathomimetic amines of histamine release induced by antigen in passively sensitized human lung. Nature 224 (1969) 1028-1029
11. Borum P., and Mygind N. Inhibition of the immediate allergic reaction in the nose by the beta-2-adrenostimulant fenoterol. J Allergy Clin Immunol 66 (1980) 25-32
12. Holt S., Suder A., Dronfield L., Holt C., and Beasley R. Intranasal β-agonist in allergic rhinitis. Allergy 55 (2000) 1198-1205
13. Ahlström-Emanuelsson C., Persson C.G.A., Svensson C., et al. Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a glucocorticosteroid. Ann Allergy Asthma Immunol 89 (2002) 159-165
14. Greiff L., Andersson M., and Persson C.G.A. Nasal secretions/exudations: collection and approaches to analysis. In: Rogers D., and Donnelly L. (Eds). Methods in molecular medicine. Vol. 56: Human airway inflammation (2001), Humana Press Inc, Totowa (NJ) 61-73
15. Bousquet J. Allergic rhinitis and its impact on asthma (ARIA). Clin Exp Allergy 3 (2003) 43-45
16. Ahlström-Emanuelsson C., Andersson M., Persson C.G.A., Schrewelius C., Åkerlund A., and Greiff L. Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis. Clin Exp Allergy 34 (2004) 731-735
17. Stern M.A., Dahl R., Nielsen L.P., Pedersen B., and Schrewelius C. A comparison of aqueous suspensions of budesonide nasal spray (128 μg and 256 μg once daily) and fluticasone propionate nasal spray (200 μg once daily) in the treatment of adult patients with seasonal allergic rhinitis. Am J Rhinol 11 (1997) 323-330
18. Bronsky E.A., Aaronson D.W., Berkowitz R.B., et al. Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis. Ann Allergy Asthma Immunol 79 (1997) 51-56
19. Meltzer E.O. Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol 81 (1998) 128-134
20. Greiff L., Andersson, Erjefält J.S., Persson C.G.A., and Wollmer P. Airway microvascular extravasation and luminal entry of plasma. Clin Physiol Funct Imag 23 (2003) 301-306
21. Russo C., Zeng D., Prosperini G., Spicuzza L., Guarino F., and Polosa R. Effect of salbutamol on nasal symptoms and mast cell degranulation induced by adenosine 5′ monophosphate nasal challenge. Clin Exp Allergy 35 (2005) 1192-1196
22. Greiff L., Wollmer P., Andersson M., Svensson C., and Persson C.G.A. Effects of formoterol on histamine challenge-induced plasma exudation in induced sputum from normal subjects. Thorax 53 (1998) 1010-1013
23. Majno G., Palade G.E., and Schoefl G.I. Studies on inflammation II. The site of action of histamine and serotonin along the vascular tree: a topographic study. J Biophys Biochem Cytol 11 (1961) 607-626
24. Grega G.J., Persson C.G.A., and Svensjö E. Endothelial cell reactions to inflammatory mediators assessed by fluid and solute flux analysis. In: Ryan U.S. (Ed). Endothelial cells (1988), CRC Press, Boca Raton 103-119